Three-day programme focuses on advanced socket design, myoelectric technology and clinical skill development
Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
C. P. Radhakrishnan urged graduates to uphold ethical standards and maintain a commitment to patient care
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
Pharma giant targets new standards of care
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
Subscribe To Our Newsletter & Stay Updated
